PB Pharma GmbH secures contract for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient pegfilgrastim, ATC L03AA13 for the period 01032025 - 28022026 (plus extension option 1x12 months)

Germany, June 17 -- Germany based PB Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient pegfilgrastim, ATC L03AA13 for the period 01032025 - 28022026 (plus extension option 1x12 months) . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....